Pharmacokinetic and pharmacodynamic modelling of the novel anti-ADAMTS-5 nanobody M6495 using the neo-epitope ARGS as a biomarker

Autor: Pereira, J. ^†, Ottevaere, I. ^‡, Serruys, B. ^‡, Dejonckheere, E. ^‡, Bay-Jensen, A.-C. ^§, Siebuhr, A.-S. ^§, El Bawab, S. ^†, Ladel, C. ^†, Lindemann, S. ^†

Publikováno v: In Osteoarthritis and Cartilage April 2018 26 Supplement 1:S176-S176

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Translational population target binding model for the anti-FcRn fragment antibody efgartigimod.

Autor: Hoefman S; LAP&P Consultants BV, Archimedesweg 31, Leiden, CM 2333, The Netherlands. S.Hoefman@lapp.nl., van Steeg T; LAP&P Consultants BV, Archimedesweg 31, Leiden, CM 2333, The Netherlands., Ottevaere I; Argenx BV, Industriepark Zwijnaarde 7, Zwijnaarde, 9052, Belgium., Baumeister J; Argenx BV, Industriepark Zwijnaarde 7, Zwijnaarde, 9052, Belgium., Rossenu S; Argenx BV, Industriepark Zwijnaarde 7, Zwijnaarde, 9052, Belgium.

Publikováno v: Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2024 Dec 05; Vol. 52 (1), pp. 2. Date of Electronic Publication: 2024 Dec 05.